The indications for anti-ageing and anti-inflammatory effects of quercetin are biologically plausible and consistent in laboratory and animal research, but the evidence in humans is still too thin to make concrete recommendations. The research is at an early stage: mechanisms have been mapped, but clinical effects in humans have not been robustly demonstrated. Anyone who decides to take quercetin on the basis of current evidence is getting ahead of the science.
Quercetin is a plant compound (a flavonoid) that occurs naturally in vegetables, fruit and herbs. The scientific community has had an interest in its potential anti-ageing effects for some time. At present, however, the positive signals come almost exclusively from animal models (such as the worm model C. elegans) and laboratory research with cells. A few small clinical studies have been conducted, but evidence in humans is limited and direct cause-and-effect relationships have not yet been demonstrated.
The anti-inflammatory effect of quercetin is the most extensively described mechanism. In laboratory and animal studies, quercetin influences inflammatory signalling pathways, including NF-kB and NAD+ metabolism. This sounds promising, but a robust clinical study demonstrating that quercetin measurably reduces inflammatory markers in humans is absent from the literature reviewed. The step from the laboratory to the living human being is a large one.
For skin ageing specifically, there is one laboratory study using human skin cells (fibroblasts) showing that quercetin in combination with the compound enoxolone enhances protective effects through improved mitochondrial function and cellular-cleaning processes (autophagy). An important caveat: that study was conducted by researchers employed by cosmetics company LG H&H, which represents a commercial interest in positive results. Moreover, it involves cell culture; effects on real human skin have not been proven.
In laboratory experiments, quercetin is regularly used as a benchmark (positive control) when testing other substances against anti-ageing enzymes such as collagenase and elastase. Quercetin shows some inhibitory activity in this context, but in at least one study a newly developed material (carbon quantum dots) proved even more potent. This confirms that quercetin is active in the lab, but says nothing about its efficacy in the human body.
Using advanced cell technology (CETSA-MS), 70 proteins have been identified to which quercetin binds directly inside cells, including proteins involved in inflammation and cell growth. This provides useful insight into how quercetin works, but the clinical significance of this remains entirely unclear. Quercetin has also been studied as part of plant extracts (including for protection of heart muscle cells against chemotherapy damage), but the individual contribution of quercetin has not been proven in isolation in that context.
All studies used are laboratory or animal research, or very small clinical studies without demonstrated causality in humans. None of the sources is a large RCT or meta-analysis specifically examining quercetin for ageing or inflammation in humans. One study has a clear commercial interest (cosmetics company LG H&H).